Oragenics
OGEN
10 hedge funds and large institutions have $13.2M invested in Oragenics in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 10 → 10 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
29% less capital invested
Capital invested by funds: $18.5M → $13.2M (-$5.36M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$17.4K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TS
1
Third Security
Radford,
Virginia
| $8.76M | – | – | – |
|
2
Fidelity Investments
Boston,
Massachusetts
| $2.49M | – | – | – |
|
|
MP
3
MSD Partners
New York
| $1.53M | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $218K | – | – | – |
|
5
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| $92.5K | – | – | – |
|
6
Geode Capital Management
Boston,
Massachusetts
| $33K | – | – | – |
|
|
7
Jacobs Levy Equity Management
Florham Park,
New Jersey
| $16K | -$17.4K | -1 | -50% |
|
8
Citadel Advisors
Miami,
Florida
| $16K | – | – | – |
|
9
Bank of America
Charlotte,
North Carolina
| $11K | – | – | – |
|
|
EEG
10
E.E. Geduld
| $9K | – | – | – |
|
|
BIM
11
BlackRock Investment Management
Wilmington,
Delaware
| $2K | – | – | – |
|
|
12
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$1K | – | – |
|
OGEN Hedge Fund Activity: Q4 2014 in Review
10 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q4 2014, worth a combined $13.2M — down 29% from $18.5M a quarter earlier.
Fund positioning in OGEN was balanced in Q4 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Jacobs Levy Equity Management, cutting an estimated $17.4K.
- 10 institutional investors held Oragenics (OGEN) as of Q4 2014, unchanged from Q3 2014.
- Funds reported $13.2M of Oragenics stock for Q4 2014, down 29% quarter-over-quarter.
- 0 funds opened new Oragenics positions in Q4 2014 and 0 closed out.
- The largest Oragenics seller in Q4 2014 was Jacobs Levy Equity Management, an estimated $17.4K sold.
Based on aggregated 13F filings for Q4 2014.